Fixed-Ratio combinations (Basal Insulin Plus GLP-1RA) in Type 2 diabetes. An analytical review of pivotal clinical trials

In type 2 diabetes, therapeutic failure to the oral anti diabetics is frequent, the use of schemes with basal insulin or with multiple doses of insulin (basal insulin and short-acting insulins) are a widely accepted way to intensify therapy. The use of GLP-1 receptor agonists is another intensificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas-Uricoechea, Hernando, Frias, Juan Pablo, Vargas-Sierra, Hernando David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SBDR - Society for Biomedical Diabetes Research 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082333/
https://www.ncbi.nlm.nih.gov/pubmed/37185053
http://dx.doi.org/10.1900/RDS.2023.19.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082333/
https://www.ncbi.nlm.nih.gov/pubmed/37185053
http://dx.doi.org/10.1900/RDS.2023.19.14

Ejemplares similares